Skip to main content

Table 4 Summary of costs collected retrospectively over the 6-month period prior to the follow-up study

From: Long term follow-up of a randomised controlled trial of services for urinary symptoms

  

CNP

SC

CNP v SC

MALE

Cost component

Mean [SE] (95% CI)

Mean [SE] (95% CI)

P-value

 

Total NHS (excl. P)

91.72 [45.00]

(3.42,180.02)

61.61 [32.36]

(-1.90,125.11)

0.2

 

Total Own Borne

2.25 [5.09]

(-7.73,12.23)

3.89 [4.40]

(-4.75,12.53)

0.6

 

Total NHS + Own (excl. P)

93.97 [48.17]

(-0.55,188.49)

65.50 [36.43]

(-5.99,136.99)

0.3

FEMALE

Cost component

Mean [SE] (95% CI)

Mean [SE] (95% CI)

P-value

 

Total NHS

84.96 [28.29]

(29.48,140.44)

60.00 [10.40]

(39.61,80.39)

0.2

 

Total Own Borne

29.22 [6.63]

(16.22,42.21)

27.67 [5.86]

(16.18,39.16)

0.6

 

Total NHS + Own

114.18 [29.18]

(56.95,171.40)

87.67 [12.36]

(63.44,111.91)

0.2

  1. Updated cost analysis using multiple imputation to deal with missing data (covariates used to impute: 4 urinary symptoms (urgency, leakage, nocturia and frequency), number of symptoms, age, body mass index & EQ-5D).